Skip to main content

WELLS FARGO & COMPANY/MN

Position in AKBA — Akebia Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA

Position in AKBA

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$136,905
-$323,175 QoQ
Shares Held
98,493
-65.5% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

WELLS FARGO & COMPANY/MN holds $924,533,657 across 59 Drug Manufacturers - Specialty & Generic names. AKBA ranks #39 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AKBA

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $136,905 98,493
2025-12-31 $460,080 285,765
2025-09-30 $518,942 190,089
2025-06-30 $580,911 159,591
2025-03-31 $249,833 130,122
2024-12-31 $232,553 122,397
2024-09-30 $131,072 99,298
2024-06-30 $98,020 96,099
2024-03-31 $14,716 8,042
2023-12-31 $13,757 11,096
2023-09-30 $12,553 11,013
2023-06-30 $10,184 11,131
2023-03-31 $6,866 12,264
2022-12-31 $7,775 13,479
2022-09-30 $4,364 13,814
2022-06-30 $5,278 14,956
2022-03-31 $212,263 295,633
2021-12-31 $786,372 347,953
2021-09-30 $419,930 145,810
2021-06-30 $74,475 19,651
2021-03-31 $366,915 108,395
2020-12-31 $729,975 260,706
2020-09-30 $782,842 311,890
2020-06-30 $4,159,865 306,323
2020-03-31 $1,837,034 242,353